Year of Low-Dose DOAC Slashes Recurrence After Provoked VTE

(MedPage Today) — MADRID — Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced recurrences without much…